Latest TGA News | Page 3

What you need to know about why it’s important to keep wearing sunscreen
Worried after sunscreen recalls? Here’s how to choose a safe one
TGA Safety Warning On Weight-loss Drugs
Taking a drug like Ozempic? What you need to know about risks of suicidal thoughts and contraception failure
Vitamin B6 products are set to be restricted. Here’s what you need to know
Reaffirming Safety Of Australia’s Vaccines
Vertex Receives TGA Approval for ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class CFTR Modulator for the Treatment of Cystic Fibrosis
Summer Moon Capital Statement on FIRB Blocking of Mayne Pharma-Cosette Acquisition
TGA works with delivery services to remove unlawful vape advertising
Digital health is changing – here’s what it means for Australians
Head of Australia’s therapeutic goods regulator appointed Chair of international regulatory coalition
Illegal vapes and cigarettes worth close to $9 million seized in joint operation
AMA President’s Update: AMA And Guild Call For Urgent Action On Medicinal Cannabis
Urgent Action Needed On Medicinal Cannabis
Australian TGA Approves Additional Indication For Telix’s Illuccix To Include Patient Selection For PSMA-Targeted Therapy
Low-cost Ketamine Treatment For Depression Found To Be Effective Long Term
New TGA Guidance Relating To Selection Criteria For Medical Device Application Audits
You can have your say On Updates To Good Manufacturing Practice Guidelines
TGA Seeks Input On Digital Mental Health Tools
Listed Medicine Compliance Reports – September 2025 Update
Therapeutic Goods Legislation Amendment Effective From 1 October 2025
Health bodies urge crackdown on rogue operators as medicinal cannabis use jumps 5455% in five years
Midnight Health Pty Ltd issued infringement notices for unlawful advertising and undertakes to comply with advertising rules
TGA and Victoria Police working together to target illegal vape sales in Melbourne
Regulation Of Melatonin Products In Australia
AMA President’s Update: Science Trumps Opinion
Drug approval provides hope for people living with Alzheimer’s
Victorian issued further infringement notices for allegedly importing unapproved therapeutic goods
A new amyloid-lowering therapy is now available for people living with early Alzheimer’s disease with the TGA registration of LEQEMBI (lecanemab)
TGA Approves Registration Of Lecanemab
Efficacy of Lysine Hydrochloride containing medicines for cold sores
Australian Prime Minister Press conference – Macquarie Group HQ, New York
Paracetamol Use In Pregnancy
GMP Clearance: backlog reduction strategy recap and next steps
Dispensed Pty Ltd issued infringement notices and directed to cease alleged unlawful advertising of medicinal cannabis
Thinking of getting botox or filler? These are the laws for cosmetic injectables
The ‘anxiety economy’ is booming. But should companies be profiting from our fears?
Sunscreen SPF Testing – Information For Sponsors
Sunscreen SPF Testing – Information For Consumers
Zero Tolerance For Illegal Vape Sales In Tasmania
Adoption of International Scientific Guidelines in Australia – R02/2024
List Of AI-enabled Medical Devices In ARTG
TGA focuses on compliance of AI and software-based medical devices
Elixir Compounding Pharmacy and Elixir Centre for Wellness issued infringement notices for the alleged unlawful advertising of therapeutic goods
Medicinal cannabis is most often prescribed for pain, anxiety and sleep. Here’s what the evidence says
Bewildering PBAC decision a missed opportunity to ensure Australian cancer patients not left behind
Follow-up TGA Statement On CHOICE SPF Sunscreen Report
Two years on from Australia’s bold psychedelic experiment, here are our concerns